Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515098 · ClinicalTrials.gov registry record · NA
Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline
A NA study of Mild Cognitive Decline, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 1
- Study location
NCT01515098: Completed NA study of Mild Cognitive Decline, sponsored by University of North Carolina, Chapel Hill.
NCT01515098 is a NA study of Mild Cognitive Decline that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01515098, a NA study of Mild Cognitive Decline, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: The purpose of this study is to examine the effect of blueberry consumption on cognitive decline and body composition in humans. Hypothesis 1: Adults with mild cognitive decline who consume blueberries will experience an improvement in cognitive abilities as measured by a standardized battery of tests, relative to those who consume a placebo. Hypothesis 2: Adults with mild cognitive decline who consume blueberries will evidence an increase in processing speed and an improvement in memory abilities as measured in an electrophysiological paradigm and compared to those who consume a placebo. Hypothesis 3: Daily intake of 35 g freeze-dried blueberries will improve body composition (fat mass vs. lean mass). Hypothesis 4: Daily intake of 35 g freeze-dried blueberries will decrease oxidative stress and inflammatory markers.
Primary Outcome
Measured by CANTAB
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Freeze-dried blueberries
- DIETARY_SUPPLEMENT Dextrose Placebo
Study Locations (1)
North Carolina
- Nutrition Research Institute - Kannapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT01515098 record still lists
NCT01515098 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Mild Cognitive Decline appearing as the primary indexed condition, and to 2 interventions - of which Freeze-dried blueberries is the first listed.
NCT01515098 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01515098 about?
NCT01515098 is a clinical study titled "Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline". Purpose: The purpose of this study is to examine the effect of blueberry consumption on cognitive decline and body composition in humans. Hypothesis 1: Adults with mild cognitive decline who consume blueberries will experience an improvement in cognitive abilities as measured by a standardized batt...
What is the current status of trial NCT01515098?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2012-01. Estimated completion is 2015-03.
What conditions does trial NCT01515098 study?
This clinical trial studies the following conditions: Mild Cognitive Decline.
What interventions are being tested in trial NCT01515098?
The interventions under investigation include: Freeze-dried blueberries (DIETARY_SUPPLEMENT), Dextrose Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01515098?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01515098 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01515098's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia